- 5 Résultats
prix le plus bas: € 177,42, prix le plus élevé: € 222,91, prix moyen: € 196,64
1
Novel Therapeutic Targets for Antiarrhythmic Drugs - George Edward Billman
Commander
sur lehmanns.de
€ 181,79
Envoi: € 0,001
CommanderLien sponsorisé
George Edward Billman:

Novel Therapeutic Targets for Antiarrhythmic Drugs - edition reliée, livre de poche

2010, ISBN: 9780470261002

Buch, Hardcover, PROFILES POTENTIAL TREATMENT APPROACHES FOR CARDIAC ARRHYTHMIAS Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americ… Plus…

Frais d'envoiLieferbar (Termin unbekannt) (EUR 0.00)
2
Novel Therapeutic Targets for Antiarrhythmic Drugs - Billman, George Edward
Commander
sur amazon.co.uk
£ 187,57
(environ € 218,45)
Envoi: € 5,591
CommanderLien sponsorisé

Billman, George Edward:

Novel Therapeutic Targets for Antiarrhythmic Drugs - Première édition

2010, ISBN: 9780470261002

Edition reliée

Wiley, Hardcover, Auflage: 1, 616 Seiten, Publiziert: 2010-01-26T00:00:01Z, Produktgruppe: Book, 0.98 kg, Wiley-Blackwell Medicine & Health Store, Special Features, Books, Books Global St… Plus…

Frais d'envoiLes coûts d'expédition peuvent différer des coûts réels. (EUR 5.59)
3
Novel Therapeutic Targets for Antiarrhythmic Drugs - Billman, George Edward
Commander
sur amazon.co.uk
£ 151,79
(environ € 177,42)
Envoi: € 5,611
CommanderLien sponsorisé
Billman, George Edward:
Novel Therapeutic Targets for Antiarrhythmic Drugs - Première édition

2010

ISBN: 9780470261002

Edition reliée

Wiley, Hardcover, Auflage: 1, 616 Seiten, Publiziert: 2010-01-26T00:00:01Z, Produktgruppe: Book, 0.98 kg, Wiley-Blackwell Medicine & Health Store, Special Features, Books, Books Global St… Plus…

Frais d'envoiIn stock. Die angegebenen Versandkosten können von den tatsächlichen Kosten abweichen. (EUR 5.61) rbmbooks
4
Novel Therapeutic Targets for Antiarrhythmic Drugs - Billman, George Edward
Commander
sur amazon.fr
€ 222,91
Envoi: € 2,991
CommanderLien sponsorisé
Billman, George Edward:
Novel Therapeutic Targets for Antiarrhythmic Drugs - nouveau livre

2010, ISBN: 9780470261002

Wiley?Blackwell, Relié, 578 Seiten, Publiziert: 2010-01-26T00:00:01Z, Produktgruppe: Livre, 2.16 kg, Livres anglais et étrangers, Boutiques, Livres, Pharmacie, Spécialités médicales, Scie… Plus…

Frais d'envoiEn stock. Les coûts d'expédition peuvent différer des coûts réels. (EUR 2.99) premium-books-europe
5
Commander
sur alibris.co.uk
€ 182,63
CommanderLien sponsorisé
Ge Billman:
Novel Therapeutic Targets for Antiarrhythmic Drugs - edition reliée, livre de poche

2001, ISBN: 9780470261002

Hardcover, PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from UK in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from… Plus…

Frais d'envoiLivraison non-comprise Fairford, GLOUCESTERSHIRE, Books2anywhere

1Comme certaines plateformes ne transmettent pas les conditions d'expédition et que celles-ci peuvent dépendre du pays de livraison, du prix d'achat, du poids et de la taille de l'article, d'une éventuelle adhésion de la plateforme, d'une livraison directe par la plateforme ou via un prestataire tiers (Marketplace), etc. il est possible que les frais de livraison indiqués par eurolivre ne correspondent pas à ceux de la plateforme qui propose l'article.

Données bibliographiques du meilleur livre correspondant

Détails sur le livre
Novel Therapeutic Targets for Antiarrhythmic Drugs

Profiles potential treatment approaches for cardiac arrhythmias Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections: * Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. * Section Two addresses safety pharmacology, including the concept of "repolarization reserve," safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs. * Section Three describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets. * Section Four describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids). Offering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, Novel Therapeutic Targets for Antiarrhythmic Drugs provides an important resource to advanced students, working researchers, and busy professionals alike.

Informations détaillées sur le livre - Novel Therapeutic Targets for Antiarrhythmic Drugs


EAN (ISBN-13): 9780470261002
ISBN (ISBN-10): 0470261005
Version reliée
Date de parution: 2010
Editeur: Wiley?Blackwell
578 Pages
Poids: 0,941 kg
Langue: eng/Englisch

Livre dans la base de données depuis 2011-12-15T15:55:56+01:00 (Zurich)
Page de détail modifiée en dernier sur 2023-08-02T18:44:09+02:00 (Zurich)
ISBN/EAN: 0470261005

ISBN - Autres types d'écriture:
0-470-26100-5, 978-0-470-26100-2
Autres types d'écriture et termes associés:
Auteur du livre: georg edward, bill george
Titre du livre: drugs


Données de l'éditeur

Auteur: George Edward Billman
Titre: Novel Therapeutic Targets for Antiarrhythmic Drugs
Editeur: John Wiley & Sons
578 Pages
Date de parution: 2010-01-26
Poids: 0,934 kg
Langue: Anglais
165,00 € (DE)
No longer receiving updates
164mm x 238mm x 34mm

BB; gebunden; Hardcover, Softcover / Chemie; Medizinische Chemie, Pharmazeutische Chemie; Kardiovaskuläre Erkrankungen; Chemistry; Drug Discovery & Development; Pharmakologie u. Pharmazeutische Medizin; Arzneimittelentwicklung; Antiarrhythmika; Wirkstoffforschung u. -entwicklung; Pharmacology & Pharmaceutical Medicine; Cardiovascular Disease; Medical Science; Chemie; Kardiovaskuläre Erkrankung; Medizin; Wirkstoffforschung u. -entwicklung; Kardiovaskuläre Erkrankungen; Pharmakologie u. Pharmazeutische Medizin

Profiles potential treatment approaches for cardiac arrhythmias Cardiac arrhythmias of ventricular origin are responsible for the deaths of nearly half a million Americans each year while atrial fibrillation accounts for about 2.3 million cases per year, a rate that is projected to increase 2.5 fold over the next half century. Effectively managing these cardiac rhythm disorders remains a major challenge for both caregivers and the pharmaceutical industry. Filling a gap in the current literature, Novel Therapeutic Targets for Antiarrhythmic Drugs presents the latest treatments for cardiac arrhythmias alongside comprehensive presentations of basic cardiac physiology and pharmacology. Written by leading experts in their research areas, this invaluable resource offers both practitioners and researchers a one-stop guide that brings together previously dispersed information. The text consists of four sections: * Section One comprehensively reviews basic cardiac electrophysiology, the mechanisms responsible for arrhythmias in the setting of ischemia, and basic pharmacology of antiarrhythmic drugs. * Section Two addresses safety pharmacology, including the concept of "repolarization reserve," safety challenges, and regulatory issues for the development of novel antiarrhythmic drugs. * Section Three describes several novel pharmacological targets for antiarrhythmic drugs, including both ion channel and non-ion channel targets. * Section Four describes promising non-pharmacological antiarrhythmic interventions including selective cardiac neural disruption or nerve stimulation, aerobic exercise training, and diet (omega-3 fatty acids). Offering an unparalleled look at the current state and future direction of cardiac arrhythmia treatment, Novel Therapeutic Targets for Antiarrhythmic Drugs provides an important resource to advanced students, working researchers, and busy professionals alike.

Autres livres qui pourraient ressembler au livre recherché:

Dernier livre similaire:
9780470561416 Novel Therapeutic Targets for Antiarrhythmic Drugs (Billman, George Edward)


< pour archiver...